Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri Lavillette

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
The Biochemical Journal|January 14, 2012
Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2Irene Boo, Kevin teWierik, Florian Douam, et al.
The Journal of Biological Chemistry|May 11, 2011
Identification of interactions in the E1E2 heterodimer of hepatitis C virus important for cell entryGuillemette Maurin, Judith Fresquet, Ophélia Granio, et al.
Plos Pathogens|March 3, 2021
A high-affinity RBD-targeting nanobody improves fusion partner's potency against SARS-CoV-2Hebang Yao, Hongmin Cai, Tingting Li, et al.
Journal of Virology|February 1, 2008
The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virusLaurent Meertens, Claire Bertaux, Lisa Cukierman, et al.
The Journal of Biological Chemistry|January 19, 2006
Significant redox insensitivity of the functions of the SARS-CoV spike glycoprotein: comparison with HIV envelopeDimitri Lavillette, Rym Barbouche, Yongxiu Yao, et al.
Plos One|June 14, 2014
The expression of the hepatocyte SLAMF3 (CD229) receptor enhances the hepatitis C virus infectionFlora Cartier, Ingrid Marcq, Florian Douam, et al.
The Journal of Biological Chemistry|December 17, 2005
Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomesDimitri Lavillette, Birke Bartosch, Delphine Nourrisson, et al.
The Journal of Biological Chemistry|November 24, 2020
The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particlesBertrand Boson, Vincent Legros, Bingjie Zhou, et al.
Vaccine|April 16, 2013
Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in miceCamille Lévy, Laetitia Aerts, Marie-Ève Hamelin, et al.
Pathogens and Global Health|November 16, 2020
Zika virus pathogenesis and current therapeutic advancesCaroline Mwaliko, Raphael Nyaruaba, Lu Zhao, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
The Biochemical Journal|January 14, 2012
Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2Irene Boo, Kevin teWierik, Florian Douam, et al.
The Journal of Biological Chemistry|May 11, 2011
Identification of interactions in the E1E2 heterodimer of hepatitis C virus important for cell entryGuillemette Maurin, Judith Fresquet, Ophélia Granio, et al.
Plos Pathogens|March 3, 2021
A high-affinity RBD-targeting nanobody improves fusion partner's potency against SARS-CoV-2Hebang Yao, Hongmin Cai, Tingting Li, et al.
Journal of Virology|February 1, 2008
The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virusLaurent Meertens, Claire Bertaux, Lisa Cukierman, et al.
The Journal of Biological Chemistry|January 19, 2006
Significant redox insensitivity of the functions of the SARS-CoV spike glycoprotein: comparison with HIV envelopeDimitri Lavillette, Rym Barbouche, Yongxiu Yao, et al.
Plos One|June 14, 2014
The expression of the hepatocyte SLAMF3 (CD229) receptor enhances the hepatitis C virus infectionFlora Cartier, Ingrid Marcq, Florian Douam, et al.
The Journal of Biological Chemistry|December 17, 2005
Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomesDimitri Lavillette, Birke Bartosch, Delphine Nourrisson, et al.
The Journal of Biological Chemistry|November 24, 2020
The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particlesBertrand Boson, Vincent Legros, Bingjie Zhou, et al.
Vaccine|April 16, 2013
Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in miceCamille Lévy, Laetitia Aerts, Marie-Ève Hamelin, et al.
Pathogens and Global Health|November 16, 2020
Zika virus pathogenesis and current therapeutic advancesCaroline Mwaliko, Raphael Nyaruaba, Lu Zhao, et al.
Pageof 8